First Time Loading...
B

Bavarian Nordic A/S
CSE:BAVA

Watchlist Manager
Bavarian Nordic A/S
CSE:BAVA
Watchlist
Price: 162.9 DKK 0.25%
Updated: May 9, 2024

Intrinsic Value

Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. [ Read More ]

The intrinsic value of one BAVA stock under the Base Case scenario is 224.44 DKK. Compared to the current market price of 162.9 DKK, Bavarian Nordic A/S is Undervalued by 27%.

Key Points:
BAVA Intrinsic Value
Base Case
224.44 DKK
Undervaluation 27%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation Backtest
Bavarian Nordic A/S

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BAVA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Bavarian Nordic A/S

Provide an overview of the primary business activities
of Bavarian Nordic A/S.

What unique competitive advantages
does Bavarian Nordic A/S hold over its rivals?

What risks and challenges
does Bavarian Nordic A/S face in the near future?

Summarize the latest earnings call
of Bavarian Nordic A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bavarian Nordic A/S.

Provide P/S
for Bavarian Nordic A/S.

Provide P/E
for Bavarian Nordic A/S.

Provide P/OCF
for Bavarian Nordic A/S.

Provide P/FCFE
for Bavarian Nordic A/S.

Provide P/B
for Bavarian Nordic A/S.

Provide EV/S
for Bavarian Nordic A/S.

Provide EV/GP
for Bavarian Nordic A/S.

Provide EV/EBITDA
for Bavarian Nordic A/S.

Provide EV/EBIT
for Bavarian Nordic A/S.

Provide EV/OCF
for Bavarian Nordic A/S.

Provide EV/FCFF
for Bavarian Nordic A/S.

Provide EV/IC
for Bavarian Nordic A/S.

Show me price targets
for Bavarian Nordic A/S made by professional analysts.

What are the Revenue projections
for Bavarian Nordic A/S?

How accurate were the past Revenue estimates
for Bavarian Nordic A/S?

What are the Net Income projections
for Bavarian Nordic A/S?

How accurate were the past Net Income estimates
for Bavarian Nordic A/S?

What are the EPS projections
for Bavarian Nordic A/S?

How accurate were the past EPS estimates
for Bavarian Nordic A/S?

What are the EBIT projections
for Bavarian Nordic A/S?

How accurate were the past EBIT estimates
for Bavarian Nordic A/S?

Compare the revenue forecasts
for Bavarian Nordic A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bavarian Nordic A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bavarian Nordic A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bavarian Nordic A/S compared to its peers.

Compare the P/E ratios
of Bavarian Nordic A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Bavarian Nordic A/S with its peers.

Analyze the financial leverage
of Bavarian Nordic A/S compared to its main competitors.

Show all profitability ratios
for Bavarian Nordic A/S.

Provide ROE
for Bavarian Nordic A/S.

Provide ROA
for Bavarian Nordic A/S.

Provide ROIC
for Bavarian Nordic A/S.

Provide ROCE
for Bavarian Nordic A/S.

Provide Gross Margin
for Bavarian Nordic A/S.

Provide Operating Margin
for Bavarian Nordic A/S.

Provide Net Margin
for Bavarian Nordic A/S.

Provide FCF Margin
for Bavarian Nordic A/S.

Show all solvency ratios
for Bavarian Nordic A/S.

Provide D/E Ratio
for Bavarian Nordic A/S.

Provide D/A Ratio
for Bavarian Nordic A/S.

Provide Interest Coverage Ratio
for Bavarian Nordic A/S.

Provide Altman Z-Score Ratio
for Bavarian Nordic A/S.

Provide Quick Ratio
for Bavarian Nordic A/S.

Provide Current Ratio
for Bavarian Nordic A/S.

Provide Cash Ratio
for Bavarian Nordic A/S.

What is the historical Revenue growth
over the last 5 years for Bavarian Nordic A/S?

What is the historical Net Income growth
over the last 5 years for Bavarian Nordic A/S?

What is the current Free Cash Flow
of Bavarian Nordic A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bavarian Nordic A/S.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bavarian Nordic A/S

Current Assets 5.4B
Cash & Short-Term Investments 1.9B
Receivables 1.8B
Other Current Assets 1.7B
Non-Current Assets 9B
PP&E 2.5B
Intangibles 6.5B
Other Non-Current Assets 15.7m
Current Liabilities 2.8B
Accounts Payable 954.1m
Accrued Liabilities 419.8m
Other Current Liabilities 1.4B
Non-Current Liabilities 1.2B
Long-Term Debt 98.8m
Other Non-Current Liabilities 1.1B
Efficiency

Earnings Waterfall
Bavarian Nordic A/S

Revenue
7.1B DKK
Cost of Revenue
-2.5B DKK
Gross Profit
4.6B DKK
Operating Expenses
-2.5B DKK
Operating Income
2.1B DKK
Other Expenses
-649m DKK
Net Income
1.5B DKK

Free Cash Flow Analysis
Bavarian Nordic A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

BAVA Profitability Score
Profitability Due Diligence

Bavarian Nordic A/S's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional 1-Year Revenue Growth
ROE is Increasing
49/100
Profitability
Score

Bavarian Nordic A/S's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

BAVA Solvency Score
Solvency Due Diligence

Bavarian Nordic A/S's solvency score is 90/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Negative Net Debt
Low D/E
High Altman Z-Score
90/100
Solvency
Score

Bavarian Nordic A/S's solvency score is 90/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BAVA Price Targets Summary
Bavarian Nordic A/S

Wall Street analysts forecast BAVA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BAVA is 272.63 DKK with a low forecast of 177.76 DKK and a high forecast of 347.55 DKK.

Lowest
Price Target
177.76 DKK
9% Upside
Average
Price Target
272.63 DKK
67% Upside
Highest
Price Target
347.55 DKK
113% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

BAVA Price
Bavarian Nordic A/S

1M 1M
+8%
6M 6M
+17%
1Y 1Y
-13%
3Y 3Y
-37%
5Y 5Y
+52%
10Y 10Y
+67%
Annual Price Range
162.9
52w Low
126.6
52w High
220.3
Price Metrics
Average Annual Return 22.9%
Standard Deviation of Annual Returns 27.01%
Max Drawdown -68%
Shares Statistics
Market Capitalization 12.7B DKK
Shares Outstanding 77 944 140
Percentage of Shares Shorted
N/A

BAVA Return Decomposition
Main factors of price return

What is price return decomposition?

BAVA News

Other Videos

Company Profile

Bavarian Nordic A/S

Country

Denmark

Industry

Biotechnology

Market Cap

12.7B DKK

Dividend Yield

0%

Description

Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate cancer, including PROSTVAC and Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) PRO; breast cancer, providing CV-301 breast and MVA-BN HER2 vaccines; and colorectal cancer, offering CV-301 colon. The Infectious Disease pipeline produces vaccines for a range of illnesses, such as smallpox, anthrax, filoviruses, foot-and-mouth diseases and respiratory syncytial virus. The firm is a parent of Bavarian Nordic GmbH, BN Infectious Diseases A/S, and Bavarian Nordic Inc, among others.

Contact

Hellerup
Philip Heymans Alle 3
+4533268383.0
https://www.bavarian-nordic.com/

IPO

1998-11-02

Employees

750

Officers

CEO & President
Dr. Paul John Chaplin MSc, Ph.D.
CFO & Executive VP
Mr. Henrik Juuel M.Sc.
Executive VP & COO
Mr. Russell Thirsk M.Sc.
Vice President of Investor Relations & Communications
Mr. Rolf Sass Sørensen
Executive VP and Chief People & Sustainability Officer
Ms. Anu Helena Kerns M.Sc.
Executive VP & Chief Commercial Officer
Mr. Jean-Christophe May M.B.A., Pharm.D.
Show More
Executive VP & Chief Medical Officer
Dr. Laurence De Moerlooze Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one BAVA stock?

The intrinsic value of one BAVA stock under the Base Case scenario is 224.44 DKK.

Is BAVA stock undervalued or overvalued?

Compared to the current market price of 162.9 DKK, Bavarian Nordic A/S is Undervalued by 27%.